When Pregnancy Becomes an Inclusion Criterion in Neuroscience Research

Amanda Tieu-Mi Huynh¹, Paula Emanuela Voinescu^{2

3}, Esther Bui⁴

Affiliations

¹ Department of Medicine and Department of Obstetrical Medicine, McMaster University, Hamilton, Ontario, Canada.
² Department of Neurology, Harvard University, Boston, Massachusetts.
³ Women's Epilepsy Program, Brigham and Women's Hospital, Boston, Massachusetts.
⁴ Neurology, Epilepsy & EEG, Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Amanda Tieu-Mi Huynh et al. JAMA Neurol. 2024.

. 2024 Jan 1;81(1):7-8.

doi: 10.1001/jamaneurol.2023.4506.

Amanda Tieu-Mi Huynh¹, Paula Emanuela Voinescu^{2

3}, Esther Bui⁴

¹ Department of Medicine and Department of Obstetrical Medicine, McMaster University, Hamilton, Ontario, Canada.
² Department of Neurology, Harvard University, Boston, Massachusetts.
³ Women's Epilepsy Program, Brigham and Women's Hospital, Boston, Massachusetts.
⁴ Neurology, Epilepsy & EEG, Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

No abstract available

Plain language summary

This Viewpoint discusses the inclusion of pregnant patients in clinical trials for antiseizure medication.